Europe Stroke Diagnostics Market by Product Type, End-Use, and Country-wise Insights: Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2032
Persistence Market Research has recently released a comprehensive report on the Europe Stroke Diagnostics Market, offering an in-depth assessment of market size, growth trends, key drivers, restrai... もっと見る
※当ページの内容はウェブ更新時の情報です。
SummaryPersistence Market Research has recently released a comprehensive report on the Europe Stroke Diagnostics Market, offering an in-depth assessment of market size, growth trends, key drivers, restraints, opportunities, and the competitive landscape. The report provides strategic insights into the evolving stroke diagnostics ecosystem across Europe, enabling stakeholders to make informed business and investment decisions.Key Insights: • Europe Stroke Diagnostics Market Size (2025E): US$ 1.1 Bn • Projected Market Value (2032F): US$ 1.6 Bn • Market Growth Rate (CAGR 2025 to 2032): 6.2% Europe Stroke Diagnostics Market – Report Scope: The Europe stroke diagnostics market includes a wide range of imaging and diagnostic technologies used to detect and evaluate different types of stroke, including ischemic stroke, hemorrhagic stroke, and transient ischemic attacks. These diagnostic solutions—such as CT scans, MRI, carotid ultrasound, cerebral angiography, and echocardiograms—are critical for early diagnosis and effective treatment planning. The market is primarily driven by the rising prevalence of stroke, an aging population, advancements in diagnostic imaging technologies, and growing awareness regarding early stroke detection. Increasing investments in healthcare infrastructure and the adoption of advanced imaging systems across European hospitals and diagnostic centers are further supporting market expansion. Market Growth Drivers: The growth of the Europe stroke diagnostics market is strongly driven by the increasing incidence of stroke across the region, largely due to aging populations and the rising prevalence of risk factors such as hypertension, diabetes, and cardiovascular diseases. Technological advancements in imaging modalities, including high-resolution MRI and rapid CT scan systems, are significantly improving diagnostic accuracy and speed, which is crucial for stroke management. Additionally, growing awareness about the importance of early diagnosis and timely intervention, supported by government initiatives and public health programs, is accelerating the adoption of advanced stroke diagnostic solutions. The expansion of well-established healthcare infrastructure and increased healthcare spending in major European countries further contribute to market growth. Market Restraints: Despite positive growth prospects, the Europe stroke diagnostics market faces certain challenges that may hinder its expansion. The high cost of advanced diagnostic imaging systems such as MRI and cerebral angiography can limit adoption, particularly in smaller healthcare facilities and cost-sensitive regions. A shortage of skilled radiologists and trained professionals required to operate sophisticated diagnostic equipment also poses a restraint. Furthermore, regulatory complexities and lengthy approval processes for new diagnostic technologies across European countries may slow product launches and market penetration. Market Opportunities: The Europe stroke diagnostics market presents significant opportunities driven by continuous innovation in medical imaging and the integration of artificial intelligence in diagnostic workflows. AI-powered imaging solutions offer faster image interpretation and improved diagnostic accuracy, creating new growth avenues for market players. The increasing focus on personalized medicine and preventive healthcare is expected to boost demand for advanced and non-invasive diagnostic tests. Additionally, expanding diagnostic imaging services in outpatient settings, specialty clinics, and ambulatory surgical centers, along with untapped opportunities in Eastern and Rest of Europe regions, is likely to create favorable growth opportunities during the forecast period. Competitive Analysis: The Europe stroke diagnostics market is moderately consolidated, with several global and regional players focusing on technological innovation, product expansion, and strategic collaborations to strengthen their market position. Key companies operating in the market include: • Siemens Healthineers • GE Healthcare • Koninklijke Philips N.V. • Canon Medical Systems Corporation • Medtronic • FUJIFILM Medical Systems • Samsung • CURVEBEAMAI • Carestream Health • Xoran Technologies • Planmed Oy • ALPINION MEDICAL SYSTEMS • Analogic Corporation • Aspect Imaging Ltd. • Esaote S.p.A Europe Stroke Diagnostics Market Segmentation By Stroke Type • Ischemic Stroke • Hemorrhagic Stroke • Transient Ischemic Attack By Diagnostic Test • CT Scan • MRI • Carotid Ultrasound • Cerebral Angiography • Echocardiogram • Others By End User • Hospitals • Diagnostic Imaging Centers • Specialty Clinics • Ambulatory Surgical Centers • Others By Country • Germany • France • U.K. • Italy • Spain • Russia • Rest of Europe Table of Contents1. Executive Summary1.1. Europe Stroke Diagnostics Market Snapshot, 2025 and 2032 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn 1.3. Key Market Trends 1.4. Future Market Projections 1.5. Premium Market Insights 1.6. Industry Developments and Key Market Events 1.7. PMR Analysis and Recommendations 2. Market Overview 2.1. Market Scope and Definition 2.2. Market Dynamics 2.2.1. Drivers 2.2.2. Restraints 2.2.3. Opportunity 2.2.4. Challenges 2.2.5. Key Trends 2.3. Macro-Economic Factors 2.3.1. Europe Sectorial Outlook 2.3.2. Europe GDP Growth Outlook 2.4. COVID-19 Impact Analysis 2.5. Forecast Factors – Relevance and Impact 3. Value Added Insights 3.1. Regulatory Landscape 3.2. Product Adoption Analysis 3.3. Disease Epidemiology 3.4. Value Chain Analysis 3.5. Key Deals and Mergers 3.6. PESTLE Analysis 3.7. Porter’s Five Force Analysis 4. Europe Stroke Diagnostics Market Outlook: 4.1. Key Highlights 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth 4.1.2. Absolute $ Opportunity 4.2. Market Size (US$ Bn) Analysis and Forecast 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025–2032 4.3. Europe Stroke Diagnostics Market Outlook: Stroke Type 4.3.1. Introduction / Key Findings 4.3.2. Historical Market Size (US$ Bn) Analysis, By Stroke Type, 2019-2024 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Stroke Type, 2025-2032 4.3.3.1. Simple Liposomes 4.3.3.2. Formulated Liposomes 4.3.3.3. Vaccines 4.3.4. Market Attractiveness Analysis: Stroke Type 4.4. Europe Stroke Diagnostics Market Outlook: Diagnostic Test 4.4.1. Introduction / Key Findings 4.4.2. Historical Market Size (US$ Bn) Analysis, By Diagnostic Test, 2019-2024 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2025-2032 4.4.3.1. Retail Sales 4.4.3.2. Distribution Sales 4.4.4. Market Attractiveness Analysis: Diagnostic Test 4.5. Europe Stroke Diagnostics Market Outlook: End User 4.5.1. Introduction / Key Findings 4.5.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2024 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032 4.5.4. Market Attractiveness Analysis: End User 5. Europe Stroke Diagnostics Market Outlook: Country 5.1. Key Highlights 5.2. Historical Market Size (US$ Bn) Analysis, By Country, 2019-2024 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032 5.3.1. Germany 5.3.2. France 5.3.3. U.K. 5.3.4. Italy 5.3.5. Spain 5.3.6. Russia 5.3.7. Rest of Europe 5.4. Market Attractiveness Analysis: Country 6. Competition Landscape 6.1. Market Share Analysis, 2024 6.2. Market Structure 6.2.1. Competition Intensity Mapping By Market 6.2.2. Competition Dashboard 6.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments) 6.3.1. Siemens Healthineers 6.3.1.1. Overview 6.3.1.2. Segments and Products 6.3.1.3. Key Financials 6.3.1.4. Market Developments 6.3.1.5. Market Strategy 6.3.2. GE Healthcare 6.3.3. Koninklijke Philips N.V. 6.3.4. Canon Medical Systems Corporation 6.3.5. Medtronic 6.3.6. FUJIFILM Medical Systems 6.3.7. Samsung 6.3.8. CURVEBEAMAI 6.3.9. Carestream Health 6.3.10. Xoran Technologies 6.3.11. Planmed Oy 6.3.12. ALPINION MEDICAL SYSTEMS 6.3.13. Analogic Corporation 6.3.14. Aspect Imaging Ltd. 6.3.15. Esaote S.p.A 7. Appendix 7.1. Research Methodology 7.2. Research Assumptions 7.3. Acronyms and Abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Persistence Market Research社の 医療・製薬・メディカルデバイス分野 での最新刊レポート
本レポートと同じKEY WORD(diagnostics)の最新刊レポート
よくあるご質問Persistence Market Research社はどのような調査会社ですか?パーシスタンスマーケットリサーチ(Persistence Market Research/PMR)は独自の方法論を用いたデータ解析と市場調査をベースに広範な産業調査報告書とカスタム調査を提供しています... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|